Play

Implantable recorders, which are placed under the skin and monitor someone’s heart for a prolonged period of time, may help identify a heart condition known as atrial fibrillation in those who’ve had a stroke, two recent studies find. Michele Johansen, …

Should you have a monitor placed under your skin to monitor your heart if you’ve had a stroke? Elizabeth Tracey reports Read more »

Play

For people who’ve had a stroke, finding out why will dictate their management going forward, with a pair of new studies showing that an implantable monitor to look for atrial fibrillation, where part of the heart doesn’t beat in synchrony, …

Finding out why a stroke took place is key to preventing a second one, Elizabeth Tracey reports Read more »

Play

“Mind the Gap” is the name of a report undertaken in Maryland to assess what may be missing in the training of nurses to help them be resilient during times such as the Covid-19 pandemic. Cynda Rushton, a professor in …

What can we learn from nurses about how to sustain them in stressful times? Elizabeth Tracey reports Read more »

Play

Medicare is poised to spend millions of dollars on aducanumab, a just approved drug for Alzheimer’s disease the FDA’s own advisory panel recommended against approving. Caleb Alexander, a member of the panel and an internal medicine expert at Johns Hopkins, …

A confirmatory trial for a new Alzheimer’s disease drug is many years away, Elizabeth Tracey reports Read more »

Play

Is amyloid, a substance that accumulates in the brains of people with Alzheimer’s disease, the cause of the disease or simply a bystander? No one knows, and that’s why an FDA advisory panel voted against approving a new drug to …

Why is a new Alzheimer’s drug so controversial? Elizabeth Tracey reports Read more »

Play

The amyloid hypothesis. That’s the idea that accumulation of a material called amyloid in the brain leads to Alzheimer’s disease. Acceptance of this idea has led the FDA to approve aducanumab, which reduces amyloid, but isn’t known to improve any …

How should drug effectiveness in Alzheimer’s disease be measured? Elizabeth Tracey reports Read more »